Talking Points: Full FDA Approval – Pfizer COVID-19 Vaccine
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
At the Utilizing Social Media to Promote Adolescent Immunization webinar, attendees heard from three speakers about engaging adolescents with vaccine-related content on social media platforms. Taylor Lombard, a researcher and medial student at Michigan State University, presented findings from her…
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
This talking points document was developed by iREACH Subject Matter Experts to provide information and resources for the 2021-2022 flu season.
The three chapters of this resource guide provide insight into how to do this. You can download a PDF of the whole guide, or each individual chapter.
Chapter 3 of the Resource Guide offers effective approaches to educating the public and policymakers, including developing outreach plans, tips for successful meetings with policymakers, and more.
Chapter 1 of the Resource Guide highlights the differences between education, advocacy, and lobbying, and helps IPs understand what is allowable with different funding sources. It also features “Key Dates in the Annual Congressional Appropriations Process,” which helps illustrate the Congressional calendar.
Chapter 2 of the Resource Guide discusses the key players that shape the immunization policy landscape in your state, highlights the benefits of partnering with them, and offers suggestions for building effective relationships.
This presentation offers key information on how Medicaid and immunization programs work together.
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.